Immunostimulatory oligonucleotides
US8552165B2 · kind B2 · utility
3Cited by
74References
4Claims
0Family size
Inventors
Key dates
| Filing date | Dec 8, 2009 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Feb 19, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to immunostimulatory oligonucleotides and methods of using immunostimulatory oligonucleotides to induce an antigen-specific immune response. The invention further relates to a vaccine that comprises an immunostimulatory oligonucleotide and an antigen, and comprises a pharmaceutically acceptable carrier. The immunostimulatory oligonucleotides of the invention, in some embodiments, include one or more modified linkage(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.